Skip to main content

Table 4 Change in haemoglobin (g/dL) (difference day 0 vs day 28) according to study cohort (AL or ASAQ) at various sites in Mozambique

From: In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children: a multisite, open-label, two-cohort, clinical trial in Mozambique

  

Study site

 
 

Variable

Montepuez

Dondo

Chokwe

Manhiça

Tete

TOTAL

Cohort 1 (artemether-lumefantrine)

Change in haemoglobin g/dL (diff. day 28 vs. day 0) arithmetic mean (SD) [n]

1.2 (1.8) [71]

1.7 (2.0) [75]

1.3 (2.2) [72]

0.5 (1.9) [73]

0.3 (8.6) [69]

1.0 (4.2) [360]

Cohort 2 (artesunate-amodiaquine)

Change in Haemoglobin g/dL (diff. D28 vs. D0) Arithmetic mean (SD) [n]

1.9 (1.5) [83]

1.8 (1.8) [78]

0.9 (1.6) [76]

N/A

N/A

1.6 (1.7) [237]